The Department of Defense (DOD), through its Neurofibromatosis Research Program (NFRP), is offering this FY11 Clinical Consortium Award. This grant is established to advance the understanding, diagnosis, and treatment of neurofibromatosis (NF). The primary purpose of this award is to fund a collaborative consortium of leading institutions and investigators. This consortium will focus on accelerating the clinical translation of foundational NF research to ultimately reduce the disease’s impact. Specifically, the grant supports the conception, design, development, and execution of collaborative Phase I and II clinical evaluations of promising therapeutic agents aimed at managing or treating both NF1 and NF2 conditions.
Opportunity ID: 92393
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-11-NFRP-CCA |
| Funding Opportunity Title: | DOD FY11 Neurofibromatosis Clinical Consortium Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 06, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 15, 2011 |
| Current Closing Date for Applications: | Sep 15, 2011 |
| Archive Date: | Oct 15, 2011 |
| Estimated Total Program Funding: | $9,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The Neurofibromatosis Research Program (NFRP) was established in 1996 to promote the understanding, diagnosis, and treatment of neurofibromatosis (NF). The vision of the FY11 NFRP is to find and fund the best research to eradicate the clinical impact of NF. The FY11 NFRP Clinical Consortium Award is intended to support a major goal/product-driven Consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic NF research and ultimately decrease the impact of the disease. The objectives of the Consortium shall be to conceive, design, develop, and conduct collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1 and NF2. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP and eReceipt HELP: 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 92393 Full Announcement-1 -> fy11_nfrp cca pa_gg.pdf
Packages
| Agency Contact Information: | PA HELP and eReceipt HELP: 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00052491 | May 06, 2011 | Sep 15, 2011 | View |
Package 1
Mandatory forms
92393 RR_SF424_1_2-1.2.pdf
92393 PerformanceSite_1_4-1.4.pdf
92393 RR_Budget-1.1.pdf
92393 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
92393 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
